Carboplatino Hikma

Carboplatin Hikma is a chemotherapy drug used to treat various types of cancer. It works by damaging the DNA of cancer cells, preventing them from growing and multiplying. This intravenous medication is manufactured by Hikma Farmacêutica (Portugal), S.A.

Carboplatin is primarily used in the treatment of ovarian cancer, lung cancer, and other solid tumors. It is often administered in combination with other chemotherapy drugs to enhance its effectiveness. The medication works by interfering with the cancer cells' ability to divide and reproduce, which helps to slow down or stop the growth of the tumor.

Common effects of Carboplatin may include nausea, vomiting, and fatigue. Some patients may also experience hair loss, loss of appetite, and changes in taste. These effects can vary in severity and may not affect everyone who takes the medication.

Carboplatin should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines when handling the medication to avoid accidental exposure. Patients should also be monitored for signs of allergic reactions or other adverse effects.

Carboplatin may interact with other medications, including certain antibiotics, antifungals, and other chemotherapy drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol should be avoided while taking Carboplatin.